-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Olema Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2019 to Q1 2025.
- Olema Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2025 was $128K, a 45.5% increase year-over-year.
- Olema Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2024 was $393K, a 4.24% increase from 2023.
- Olema Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $377K, a 5.6% increase from 2022.
- Olema Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $357K, a 119% increase from 2021.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)